Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
59.2M
-
Shares change
-
+1.01M
-
Total reported value, excl. options
-
$536M
-
Value change
-
+$8.9M
-
Put/Call ratio
-
1
-
Number of buys
-
42
-
Number of sells
-
-58
-
Price
-
$9.06
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q2 2022
129 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q2 2022.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59.2M shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (13.4M shares), Madison Avenue Partners, LP (7.27M shares), VANGUARD GROUP INC (6.54M shares), Weiss Asset Management LP (6.24M shares), Park West Asset Management LLC (3.17M shares), FMR LLC (2.7M shares), Woodline Partners LP (2.24M shares), Newtyn Management, LLC (2.04M shares), STATE STREET CORP (1.5M shares), and D. E. Shaw & Co., Inc. (1.38M shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.